21 hours ago • ajmc.com
Phase 3 IRAKLIA Trial Compares On-Body vs IV Isatuximab in RRMM: Xavier Leleu, MD, PhD
21 hours ago • ajmc.com
Phase 3 IRAKLIA Trial Compares On-Body vs IV Isatuximab in RRMM: Xavier Leleu, MD, PhD2025-06-15 • PR Newswire
Investigational combination of first-in-class bispecifics TALVEY® and TECVAYLI® shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease2025-06-14 • globenewswire.com
Starton Therapeutics Announces Phase 2a Clinical Trial for Continuous Low-Dose Lenalidomide (STAR-LLD) in Multiple Myeloma Open for Enrollment2025-06-13 • ajmc.com
ADVANCE Trial Supports DKRd as New Standard of Care for Newly Diagnosed Multiple Myeloma: Ola Landgren, MD, PhD2025-06-12 • prnewswire.co.uk
Real-world prospective data confirms improved risk stratification in multiple myeloma using SKY92 gene expression profiling2025-06-06 • oncologynewscentral.com
Myeloma Quadruplet Doubles Sustained MRD Negativity in Transplant-Eligible Patients2025-06-05 • geneonline.com
Phase 1 Trial Shows 79 Percent Response Rate for ISB 2001 in Relapsed Multiple Myeloma2025-06-04 • ascopost.com
Potential New Standard of Care Emerges in Multiple Myeloma2025-06-04 • stocktitan.net
Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual Meeting2025-06-03 • PR Newswire
DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)-based regimen shows 95 percent progression-free survival at four years in transplant-eligible, newly diagnosed patients with multiple myeloma who achieved sustained MRD negativity2025-06-03 • PR Newswire
Single infusion of CARVYKTI® (ciltacabtagene autoleucel) delivered lasting treatment-free remissions for at least five years in patients with relapsed or refractory multiple myeloma2025-06-03 • PR Newswire
Early results from Johnson & Johnson's trispecific antibody show promising response in heavily pretreated multiple myeloma patients2025-06-03 • clinicaltrialsarena.com
ASCO25: J&J’s Carvykti shows strong efficacy across multiple myeloma risk groups2025-06-03 • EIN Presswire
Researchers develop a new ultrasensitive method that detects residual disease in patients with multiple myeloma2025-06-02 • PR Newswire
Full Dose-Escalation Data Show Continued High Response Rates and Favorable Safety Profile of ISB 2001, a First-in-Class BCMA × CD38 × CD3 Trispecific Antibody, for the Treatment of Relapsed/Refractory Multiple Myeloma2025-05-26 • geneonline.com
FDA Advisory Panel Recommends Johnson & Johnson’s Darzalex for Early-Stage Multiple Myeloma Treatment2025-05-24 • stocktitan.net
Linvoseltamab in Combination with Carfilzomib or Bortezomib Shows Promising Initial Results in Earlier Lines of Treatment for Relapsed/Refractory Multiple Myeloma2025-05-21 • medicaldialogues.in
GSK Blenrep Combos Win Approval In Japan For Multiple Myeloma2025-05-21 • PR Newswire
U.S. FDA Oncologic Drugs Advisory Committee votes in favor of the benefit-risk profile of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for high-risk smoldering multiple myeloma2025-05-20 • directorstalkinterviews.com
GSK Plc receives Japan approval for Blenrep combinations in multiple myelomaJust now • prnewswire.co.uk
Astronergy sets the pace at SNEC 2025 with cutting-edge solar products and global partnershipsJust now • prnewswire.co.uk
Discover the Superhero Within: New Book Stories with Purpose by Laura G. Patac Helps Readers Turn Life's Challenges into PurposeJust now • prnewswire.co.uk
Finastra Lands Top Payments Software Ranking with IBSi Sales League TableJust now • prnewswire.co.uk
2025 ICIS Top 100 Chemical Distributors Ranking RevealedJust now • prnewswire.co.uk
Zentiva acquires heritage brands from Aboca to expand natural-based Consumer Healthcare solutions across Europe2 hours ago • nagalandtribune.in
Tripura has begun experimental soilless hydroponic farming: Minister2 hours ago • prnewswire.co.uk
Tetragon Financial Group Limited Announces Sale of Minority Equitix Stake to Hunter Point Capital4 hours ago • prnewswire.co.uk
Education Cannot Wait for the Children of Africa16 hours ago • theglobeandmail.com
Viking Therapeutics Stock (VKTX): This Underrated Russell 2000 Gem Could Skyrocket 200%16 hours ago • foxbusiness.com
Bethenny Frankel sells her Connecticut mansion for nearly $8M after major renovation16 hours ago • ept.ca
1200V SiC MOSFET delivers top-side cooling, isolated thermal path16 hours ago • organiser.org
Kerala Indian Coast Guard Secures Drifting Cargo Ship Mv Wan Hai 503 Off KochiJust now • PR Newswire
HACR Presents the HACR Young Hispanic Corporate Achievers™ Class of 2025 GraduatesJust now • PR Newswire
NSSC Shareholders Have the Right to Lead the Napco Security Technologies, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - NSSCJust now • PR Newswire
BITF Shareholders Have the Right to Lead the Bitfarms Ltd. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - BITF2025-06-14 • eutoday.net
EU Set to Demand Full Disclosure of Russian Gas Contracts as Part of 2027 Phase-Out Plan22 hours ago • agronews.ua
EU introduces tariffs on all agricultural imports from Russia22 hours ago • nikvesti.com
Chemical plant producing components for explosives attacked in RussiaJust now • PR Newswire
Ravin Group Wins 'Outstanding Component Supplier for Railway Infrastructure' at ET Infra Rail Show Awards 20252 hours ago • nagalandtribune.in
Tripura has begun experimental soilless hydroponic farming: Minister3 hours ago • businesswireindia.com
Mirai School of Technology Is Changing Engineering in India - Here’s How Students Are Learning AI from Day One30 minutes ago • EIN Presswire
Biosecure ID Welcomes Natalie Tyler as Chief Commercial Officer to Lead Mission-Driven Global Forensic Science Solutions45 minutes ago • EIN Presswire
Rail Brace Market to Hit USD 95.1 Billion by 2035 Driven by Infrastructure Growth and Rising Safety Standards1 hour ago • EIN Presswire
Pet Care Market to Reach USD 483.5 Billion by 2035, Driven by Pet Humanization, Premiumization, and Tech AdvancementsStay ahead with real-time headlines from top sources, categorized by sector and country.